Related Experiment Videos
Immunologic tolerance in renal transplantation
1Department of Surgery, UCLA School of Medicine, Harbor-UCLA Medical Center 90509, USA.
World Journal of Urology
|January 1, 1996
Summary
Achieving transplant tolerance, or long-term acceptance of organ transplants without immunosuppression, remains challenging in humans. However, research advances are leading to promising new clinical approaches for inducing tolerance.
Area of Science:
- Immunology
- Transplantation Science
- Nephrology
Background:
- Current renal transplantation success relies on immunosuppression, which carries risks like infection, malignancy, and chronic allograft nephropathy.
- The goal of transplantation tolerance—long-term graft acceptance without immunosuppression—has been pursued for decades.
- Achieving tolerance has been more successful in rodents than humans, but research has deepened understanding of immune self/non-self discrimination.
Purpose of the Study:
- To review the challenges and progress in inducing transplantation tolerance.
- To highlight the importance of understanding immune self/non-self discrimination for tolerance induction.
- To discuss emerging clinical approaches for achieving transplant tolerance.
Main Methods:
- Review of existing literature on transplantation tolerance and immunosuppression.
- Analysis of immunological mechanisms underlying self/non-self recognition.
- Evaluation of current clinical trials for tolerance induction strategies.
Main Results:
- Chronic immunosuppression, while effective short-term, leads to significant long-term complications.
- Significant advancements in understanding immune system function have been made.
- Several novel strategies for inducing clinical transplant tolerance are now in development and evaluation.
Conclusions:
- Transplant tolerance is a critical but challenging goal in organ transplantation.
- Insights into immune self/non-self discrimination are paving the way for new tolerance strategies.
- Promising clinical approaches are emerging, offering hope for reduced long-term immunosuppression burden.